Open AccessInsights into erlotinib action in pancreatic cancer cells using a combined experimental and mathematical approach
Author(s) -
Falko Lange,
Katja Rateitschak,
Christina Kossow,
Olaf Wolkenhauer,
Robert Jaster
Publication year - 2012
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v18.i43.6226
Subject(s) - erlotinib , protein kinase b , mapk/erk pathway , epidermal growth factor receptor , cancer research , kinase , mek inhibitor , epidermal growth factor , phosphorylation , chemistry , microbiology and biotechnology , cell growth , pancreatic cancer , egfr inhibitors , biology , cell culture , biochemistry , cancer , receptor , genetics
To gain insights into the molecular action of erlotinib in pancreatic cancer (PC) cells.